ALNYNasdaq United States
Market cap
$29.331 B
$219.20 +1.43%
Close of 7 Aug 2026
Revenue
$3.71B
#816 by revenue
Earnings
$313.7M
#821 by earnings
Shares outstanding
133,809,118
Latest filing cover page
P/E ratio
93.5
Cap ÷ net income
Where these numbers come from
Share counts and financials for Alnylam Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.